Hakkında
Dr Mohammed Abdul-latif is a Consultant Clinical Oncologist with a specialist interest in urological and gynaecological malignancies, as well as complex brachytherapy. He serves as the Clinical Lead for the brachytherapy department at Mount Vernon Cancer Centre, where he delivers advanced brachytherapy treatments for a range of cancers.
He graduated in the top decile of his cohort from Imperial College School of Medicine in 2013. Following graduation, he undertook postgraduate training in North London hospitals, rotating through general medicine and clinical oncology. He has completed a Postgraduate Diploma (PGDip) in Oncology and a Doctorate of Medicine (MD) at the University of Manchester under the supervision of Professor Peter Hoskin. His doctoral research focused on the role of functional MRI in cervical cancer. He continues to publish academic work and regularly presents at international conferences, including ESTRO.
Dr Abdul-latif is trained in the delivery of complex brachytherapy for gynaecological, urological, oesophageal, and rectal cancers, including contact radiotherapy. He also performs interstitial treatments for rarer cancers such as those of the skin, breast, and soft tissues. He routinely implants hydrogel spacers (SpaceOAR) as part of prostate cancer treatment protocols.
He has a keen interest in the delivery of systemic therapies, managing patients with requiring chemotherapy, targeted therapies and immunotherapy in a range of settings.
He was awarded the Royal College of Radiologists' Kay-Durrant Fellowship, which enabled him to travel to France and Italy to gain additional experience in breast, rectal, and head and neck brachytherapy.
He graduated in the top decile of his cohort from Imperial College School of Medicine in 2013. Following graduation, he undertook postgraduate training in North London hospitals, rotating through general medicine and clinical oncology. He has completed a Postgraduate Diploma (PGDip) in Oncology and a Doctorate of Medicine (MD) at the University of Manchester under the supervision of Professor Peter Hoskin. His doctoral research focused on the role of functional MRI in cervical cancer. He continues to publish academic work and regularly presents at international conferences, including ESTRO.
Dr Abdul-latif is trained in the delivery of complex brachytherapy for gynaecological, urological, oesophageal, and rectal cancers, including contact radiotherapy. He also performs interstitial treatments for rarer cancers such as those of the skin, breast, and soft tissues. He routinely implants hydrogel spacers (SpaceOAR) as part of prostate cancer treatment protocols.
He has a keen interest in the delivery of systemic therapies, managing patients with requiring chemotherapy, targeted therapies and immunotherapy in a range of settings.
He was awarded the Royal College of Radiologists' Kay-Durrant Fellowship, which enabled him to travel to France and Italy to gain additional experience in breast, rectal, and head and neck brachytherapy.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Mohammed Abdul-latif
Eğitim ve öğretim
-
2002–2008 MD · Medicine and Surgery
-
2008–2012 Residency · Onkoloji
-
2012–2013 Fellowship · Subspecialty training
Kariyer ve atamalar
-
2012-09–2013-08 Junior consultant
Lisanslar ve sigorta
Tıbbi lisanslar
GB — Organización Médica Colegial de España (OMC)
Kurul sertifikaları
European Board of Onkoloji
Mesleki sorumluluk sigortası:
HDI Global · 5,000,000 EUR kapsam · No claims on file
Gerçekleştirilen prosedürler
| Prosedür | Kod | Toplam sayı |
|---|---|---|
| GP consultation | 99213 | 1,413 |
| Annual physical exam | 99395 | 435 |
| Vaccination administration | 90471 | 2,499 |
| Minor procedure (skin) | 17110 | 2,868 |
Hizmetler ve fiyatlandırma
| Hizmet | Süre | Yöntem | Fiyat |
|---|---|---|---|
| New patient consultation (60m) | 60 dk | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 dk | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 120 dk | in_clinic | 810.00 EUR |
| Minor procedure (skin) | 30 dk | in_clinic | 540.00 EUR |
Ofis, ekip ve uygulamada
Videolar
Araştırma ve yayınlar
h-endeksi: 19 · i10: 7
-
European registry analysis of Onkoloji outcomes
DOI: 10.5319/euroclin.2025.0 · PMID: 35622372 · alıntılayan 85
-
Outcomes of Onkoloji in adults — a multi-centre cohort
DOI: 10.5304/euroclin.2024.1 · PMID: 34197352 · alıntılayan 151
Davetli konuşmalar
- Practical updates in Onkoloji European Annual Congress (Onkoloji) · Vienna · 2024 · invited
- Single-centre experience in Onkoloji National Society Meeting · Northwood · 2023 · oral abstract
Ödüller ve üyelikler
Ödüller
- 🏆 Top-rated Onkoloji — Northwood · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
Topluluk üyelikleri
- WONCA Europe — Family Doctors — Member · 2013 yılından beri
- national college of family doctors — Member · 2013 yılından beri
- European Union of Medical Specialists (UEMS) — Member · 2013 yılından beri
Bu doktorun makaleleri
- Patient education Patient guide to Onkoloji
- Awareness When should you see a onkoloji?
Uluslararası hastalar için
- Koordinatör
- Patient liaison · mohammed.abdul.latif@euroclinics.example
- Kabul edilen uluslararası sigortalar
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
Konum
1 etiketHasta yorumları
1 doğrulanmış yorum5.00
★★★★★
1 yorum
- Bedside Manner
- 5.0
- Knowledge
- 5.0
- Wait Time
- 4.8
- Staff Friendliness
- 5.0
- Ease Of Appointment
- 4.9
- Value For Money
- 4.9
- Would Recommend Pct
- 99.0
Deneyiminizi paylaşın — diğer hastaların doğru doktoru bulmasına yardımcı olun. Yorum yaz →
Son yorumlar
-
★★★★★ ✓ Doğrulanmış Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Doğrulanmış Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Doğrulanmış Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.